Home

Tara Lynn Kieffer, Chief Product Strategy Officer: Enanta Pharmaceuticals ENTA Sell · Filed 24/06/17

Trade details

Type
Insider sale
Amount
$89,589.78
Shares · price
7,266 sh · $12.33 a share
Held after
32,341 sh
Trade date
24/06/17
Filed
24/06/17
Days to filing
0 days

Sold 18.3% of holdings

Share of holding sold
18.3%

Enanta Pharmaceuticals trades, last 26 weeks

What else happened in Enanta Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/05/18~24/07/17

Tara Lynn Kieffer's recent trades

  • Tara Lynn Kieffer

    SellEnanta Pharmaceuticals

    $30K

    Filed 25/12/05

  • Tara Lynn Kieffer

    Sell10b5-1 planEnanta Pharmaceuticals

    $18.4K

    Filed 24/12/10

  • Tara Lynn Kieffer

    SellEnanta Pharmaceuticals

    $20.5K

    Filed 23/12/06